Roles of kupffer cells in liver transplantation

Hepato-Gastroenterology

Volumn 59, Issue 116, 2012, Pages 1251-1257

  Huang, Han Fei ^a   Zeng, Zhong ^a   Chen, Ming Qing ^a  

^a KUNMING MEDICAL UNIVERSITY   (China)

Author keywords

Acute rejection; Chronic rejection; Heme oxygenase 1; Ischemia reperfusion injury; Kupffer cells; Liver transplantation

Indexed keywords

HEME OXYGENASE 1;

ANTIGEN PRESENTING CELL; HISTOCOMPATIBILITY; HOST RESISTANCE; INNATE IMMUNITY; KUPFFER CELL; LIVER GRAFT REJECTION; LIVER ISCHEMIA; LIVER TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPERFUSION INJURY; REVIEW;

ANIMALS; GRAFT REJECTION; HEME OXYGENASE-1; HUMANS; IMMUNE TOLERANCE; KUPFFER CELLS; LIVER; LIVER TRANSPLANTATION; REPERFUSION INJURY;

EID: 84861413625     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: 10.5754/hge12046     Document Type: Review

References (99)

1. Naito M, Hasegawa G, Ebe Y, Yamamoto T: Differentiation and function of Kupffer cells. Med Electron Microsc 2004; 37(1):16-28.
2. Wisse E: Observations on the fine structure and peroxidase cytochemistry of normal rat liver Kupffer cells. J Ultrastruct Res 1974; 46(3):393-426.
3. Wisse E: Kupffer cell reactions in rat liver under various conditions as observed in the electron microscope. J Ultrastruct Res 1974; 46(3):499-520.
4. Naito M, Hasegawa G, Takahashi K: Development, differentiation and maturation of Kupffer cells. Microsc Res Tech 1997; 39(4):350-364.
5. Bouwens L, Baekeland M, De Zanger R, Wisse E: Quantitation, tissue distribution and proliferation kinetics of Kupffer cells in normal rat liver. Hepatology 1986; 6(4):718-722.
6. Bouwens L, Knook DL, Wisse E: Local proliferation and extrahepatic recruitment of liver macrophages (Kupffer cells) in partial-body irradiated rats. J Leukoc Biol 1986; 39(6):687-697.
7. Naito M, Takahashi K: The role of Kupffer cells in glucan-induced granuloma formation in the liver of mice depleted of blood monocytes by administration of strontium-89. Lab Invest 1991; 64(5):664-674.
8. Yamada M, Naito M, Takahashi K: Kupffer cell proliferation and glucan-induced granuloma formation in mice depleted of blood monocytes by strontium-89. J Leukoc Biol 1990; 47(3):195-205.
9. Decker K: Biologically active products of stimulated liver macrophages (Kupffer cells). Eur J Biochem 1990; 192(2):245-261.
10. Clavien PA, Harvey PR, Sanabria JR, Cywes R, Levy GA, Strasberg SM: Lymphocyte adherence in the reperfused rat liver: mechanisms and effects. Hepatology 1993; 17(1):131-142.
11. Urata K, Brault A, Rocheleau B, Huet PM: Role of Kupffer cells in the survival after rat liver transplantation with long portal vein clamping times. Transpl Int 2000; 13(6):420-427.
12. Jaeschke H, Farhood A: Kupffer cell activation after no-flow ischemia versus hemorrhagic shock. Free Radic Biol Med 2002; 33(2):210-219.
13. Giakoustidis DE, Iliadis S, Tsantilas D, et al.: Blockade of Kupffer cells by gadolinium chloride reduces lipid peroxidation and protects liver from ischemia/reperfusion injury. Hepato-gastroenterol 2003; 50(53):1587-1592.
14. Videla LA, Fernandez V, Tapia G, Varela P: Oxidative stress-mediated hepatotoxicity of iron and copper: role of Kupffer cells. Biometals 2003; 16(1):103-111.
15. Shibuya H, Ohkohchi N, Seya K, Satomi S: Kupffer cells generate superoxide anions and modulate reperfusion injury in rat livers after cold preservation. Hepatology 1997; 25(2):356-360.
16. Cazanave S, Vadrot N, Tinel M, et al.: Ibuprofen administration attenuates serum TNF-alpha levels, hepatic glutathione depletion, hepatic apoptosis and mouse mortality after Fas stimulation. Toxicol Appl Pharmacol 2008; 231(3):336-343.
17. Eipel C, Kidess E, Abshagen K, et al.: Antileukoproteinase protects against hepatic inflammation, but not apoptosis in the response of D-galactosamine-sensitized mice to lipopolysaccharide. Br J Pharmacol 2007; 151(3):406-413.
18. Langdale LA, Hoagland V, Benz W, et al.: Suppressor of cytokine signaling expression with increasing severity of murine hepatic ischemia-reperfusion injury. J Hepatol 2008; 49(2):198-206.
19. Zhang JX, Wu HS, Wang H, Zhang JH, Wang Y, Zheng QC: Protection against hepatic ischemia/reperfusion injury via down-regulation of toll-like receptor 2 expression by inhibition of Kupffer cell function. World J Gastroenterol 2005; 11(28):4423-4426.
20. Vollmar B, Menger MD: The hepatic microcirculation: mechanistic contributions and therapeutic targets in liver injury and repair. Physiol Rev 2009; 89(4):1269-1339.
21. Shibuya H, Ohkohchi N, Tsukamoto S, Satomi S: Tumor necrosis factor-induced, superoxide-mediated neutrophil accumulation in cold ischemic/reperfused rat liver. Hepatology 1997; 26(1):113-120.
22. Schwabe RF, Brenner DA: Mechanisms of Liver Injury. I. TNF-alpha-induced liver injury: role of IKK, JNK, and ROS pathways. Am J Physiol Gastrointest Liver Physiol 2006; 290(4):G583-589.
23. Kato A, Gabay C, Okaya T, Lentsch AB: Specific role of interleukin-1 in hepatic neutrophil recruitment after ischemia/reperfusion. Am J Pathol 2002; 161(5):1797-1803.
24. Zhu H, Marco C, Gianfranco F: Early changes of graft function, cytokines and superoxide dismutase serum levels after donor liver denervation and Kupffer cell depletion in a rat-to-rat liver transplantation model. Hepatobiliary Pancreat Dis Int 2009; 8(2):152-156.
25. Serracino-Inglott F, Habib NA, Mathie RT: Hepatic ischemia-reperfusion injury. Am J Surg 2001; 181(2):160-166.
26. Kox WJ, Volk T, Kox SN, Volk HD: Immunomodulatory therapies in sepsis. Intensive Care Med 2000; 26(1):S124-128.
27. Sun Z, Klein AS, Radaeva S, et al.: In vitro interleukin-6 treatment prevents mortality associated with fatty liver transplants in rats. Gastroenterology 2003; 125(1):202-215.
28. Matsumoto T, O'Malley K, Efron PA, et al.: Interleukin-6 and STAT3 protect the liver from hepatic ischemia and reperfusion injury during ischemic preconditioning. Surgery 2006; 140(5):793-802.
29. Chen YX, Sato M, Kawachi K, Abe Y: Neutrophil-mediated liver injury during hepatic ischemia-reperfusion in rats. Hepatobiliary Pancreat Dis Int 2006; 5(3):436-442.
30. Kihara K, Ueno S, Sakoda M, Aikou T: Effects of hyperbaric oxygen exposure on experimental hepatic ischemia reperfusion injury: relationship between its timing and neutrophil sequestration. Liver Transpl 2005; 11(12):1574-1580.
31. Karidis NP, Kouraklis G, Theocharis SE: Platelet-activating factor in liver injury: a relational scope. World J Gastroenterol 2006; 12(23):3695-3706.
32. Ruan Z, Shibamoto T, Shimo T, et al.: Effects of platelet-activating factor and thromboxane A2 on isolated perfused guinea pig liver. Prostaglandins Other Lipid Mediat 2004; 73(1-2):73-85.
33. Yamakawa Y, Takano M, Patel M, Tien N, Takada T, Bulkley GB: Interaction of platelet activating factor, reactive oxygen species generated by xanthine oxidase, and leukocytes in the generation of hepatic injury after shock/resuscitation. Ann Surg 2000; 231(3):387-398.
34. Souza DG, Pinho V, Soares AC, Shimizu T, Ishii S, Teixeira MM: Role of PAF receptors during intestinal ischemia and reperfusion injury. A comparative study between PAF receptor-deficient mice and PAF receptor antagonist treatment. Br J Pharmacol 2003; 139(4):733-740.
35. Ozturk H, Yagmur Y: PAF antagonist BN-52021 reduces inter-cellular adhesion molecule-1 expression and oxidative stress in rats with reperfusion damage due to unilateral testicular torsion. Pediatr Surg Int 2006; 22(2):191-196.
36. Ohkohchi N: Suppression of Kupffer cell function is a key for liver transplantation from the non-heart-beating donor. Transplant Proc 2001; 33(7-8):3728-3731.
37. Frangogiannis NG, Mendoza LH, Lindsey ML, et al.: IL-10 is induced in the reperfused myocardium and may modulate the reaction to injury. J Immunol 2000; 165(5):2798-2808.
38. Zingarelli B, Yang Z, Hake PW, Denenberg A, Wong HR: Absence of endogenous interleukin 10 enhances early stress response during post-ischaemic injury in mice intestine. Gut 2001; 48(5):610-622.
39. Bauer I, Wanner GA, Rensing H, et al.: Expression pattern of heme oxygenase isoenzymes 1 and 2 in normal and stress-exposed rat liver. Hepatology 1998; 27(3):829-838.
40. Geuken E, Buis CI, Visser DS, et al.: Expression of heme oxygenase-1 in human livers before transplantation correlates with graft injury and function after transplantation. Am J Transplant 2005; 5(8):1875-1885.
41. Coito AJ, Buelow R, Shen XD, et al.: Heme oxygenase-1 gene transfer inhibits inducible nitric oxide synthase expression and protects genetically fat Zucker rat livers from ischemia-reperfusion injury. Transplantation 2002; 74(1):96-102.
42. Kobayashi T, Sato Y, Yamamoto S, et al.: Augmentation of heme oxygenase-1 expression in the graft immediately after implantation in adult living-donor liver transplantation. Transplantation 2005; 79(8):977-980.
43. Kato H, Amersi F, Buelow R, et al.: Heme oxygenase-1 over-expression protects rat livers from ischemia/reperfusion injury with extended cold preservation. Am J Transplant 2001; 1(2):121-128.
44. Hirano K, Kobayashi T, Watanabe T, et al.: Role of heme oxygenase-1 and Kupffer cells in the production of bilirubin in the rat liver. Arch Histol Cytol 2001; 64(2):169-178.
45. Kyokane T, Norimizu S, Taniai H, et al.: Carbon monoxide from heme catabolism protects against hepatobiliary dysfunction in endotoxin-treated rat liver. Gastroenterology 2001; 120(5):1227-1240.
46. Zeng Z, Huang HF, Chen MQ, Song F, Zhang YJ: Heme oxygenase-1 protects donor livers from ischemia/reperfusion injury: the role of Kupffer cells. World J Gastroenterol 2010; 16(10):1285-1292.
47. Devey L, Ferenbach D, Mohr E, et al.: Tissue-resident macrophages protect the liver from ischemia reperfusion injury via a heme oxygenase-1-dependent mechanism. Mol Ther 2009; 17(1):65-72.
48. Wunder C, Brock RW, McCarter SD, et al.: Inhibition of haem oxygenase activity increases leukocyte accumulation in the liver following limb ischaemia-reperfusion in mice. J Physiol 2002; 540(Pt3):1013-1021.
49. Tuzuner E, Liu L, Shimada M, et al.: Heme oxygenase-1 protects human hepatocytes in vitro against warm and cold hypoxia. J Hepatol 2004; 41(5):764-772.
50. McNally SJ, Harrison EM, Ross JA, Garden OJ, Wigmore SJ: Curcumin induces heme oxygenase-1 in hepatocytes and is protective in simulated cold preservation and warm reperfusion injury. Transplantation 2006; 81(4):623-626.
51. Tamion F, Richard V, Lacoume Y, Thuillez C: Intestinal pre-conditioning prevents systemic inflammatory response in hemorrhagic shock. Role of HO-1. Am J Physiol Gastrointest Liver Physiol 2002; 283(2):G408-414.
52. Tamion F, Richard V, Renet S, Thuillez C: Intestinal preconditioning prevents inflammatory response by modulating heme oxygenase-1 expression in endotoxic shock model. Am J Physiol Gastrointest Liver Physiol 2007; 293(6):G1308-1314.
53. Jancso G, Cserepes B, Gasz B, et al.: Expression and protective role of heme oxygenase-1 in delayed myocardial preconditioning. Ann NY Acad Sci 2007; 1095:251-261.
54. Lai IR, Chang KJ, Chen CF, Tsai HW: Transient limb ischemia induces remote preconditioning in liver among rats: the protective role of heme oxygenase-1. Transplantation 2006; 81(9):1311-1317.
55. Zeng Z, Huang HF, Chen MQ, Song F, Zhang YJ: Postconditioning prevents ischemia/reperfusion injury in rat liver transplantation. Hepato-gastroenterol 2010; 57(101):875-881.
56. Kaizu T, Nakao A, Tsung A, et al.: Carbon monoxide inhalation ameliorates cold ischemia/reperfusion injury after rat liver transplantation. Surgery 2005; 138(2):229-235.
57. Kaizu T, Ikeda A, Nakao A, et al.: Protection of transplant-induced hepatic ischemia/reperfusion injury with carbon monoxide via MEK/ERK1/2 pathway downregulation. Am J Physiol Gastrointest Liver Physiol 2008; 294(1):G236-244.
58. De Backer O, Elinck E, Blanckaert B, Leybaert L, Motterlini R, Lefebvre RA: Water-soluble CO-releasing molecules reduce the development of postoperative ileus via modulation of MAPK/HO-1 signalling and reduction of oxidative stress. Gut 2009; 58(3):347-356.
59. Farombi EO, Surh YJ: Heme oxygenase-1 as a potential therapeutic target for hepatoprotection. J Biochem Mol Biol 2006; 39(5):479-491.
60. Akamatsu Y, Ohkohchi N, Doi H, Satomi S: Effect of elimination of donor Kupffer cells and/or recipient macrophages on acute rejection in liver transplantation. Hepato-gastroenterol 2003; 50(52):1105-1110.
61. Clouston AD, Jonsson JR, Balderson GA, et al.: Lymphocyte apoptosis and cell replacement in human liver allografts. Transplantation 2002; 73(11):1828-1834.
62. Tox U, Burkhardt MA, Benz C, et al.: Expression of apoptosis and apoptosis-related peptides in various stages of rejection in the human transplanted liver. Hepato-gastroenterol 2001; 48(42):1697-1700.
63. Yamaguchi Y, Okabe K, Matsumura F, et al.: Peroxynitrite formation during rat hepatic allograft rejection. Hepatology 1999; 29(3):777-784.
64. Liu H, Cao H, Wu ZY: Isolation of Kupffer cells and their suppressive effects on T lymphocyte growth in rat orthotopic liver transplantation. World J Gastroenterol 2007; 13(22):3133-3136.
65. Kwekkeboom J, Kuijpers MA, Bruyneel B, et al.: Expression of CD80 on Kupffer cells is enhanced in cadaveric liver transplants. Clin Exp Immunol 2003; 132(2):345-351.
66. Sun Z, Wada T, Maemura K, et al.: Hepatic allograft-derived Kupffer cells regulate T cell response in rats. Liver Transpl 2003; 9(5):489-497.
67. Deaciuc I, D'Souza N, Nikolova-Karakashian M, et al.: The regulation of Fas (CD95/Apo-1)-mediated liver apoptosis in Kupffer cell-depleted mice. Hepatol Res 2002; 24(2):192.
68. Miyagawa-Hayashino A, Tsuruyama T, Egawa H, et al.: FasL expression in hepatic antigen-presenting cells and phagocytosis of apoptotic T cells by FasL+ Kupffer cells are indicators of rejection activity in human liver allografts. Am J Pathol 2007; 171(5):1499-1508.
69. Nagakawa Y, Nomoto S, Kato Y, et al.: Over-expression of AIF-1 in liver allografts and peripheral blood correlates with acute rejection after transplantation in rats. Am J Transplant 2004; 4(12):1949-1957.
70. Liu G, Ma H, Jiang L, Zhao Y: Allograft inflammatory factor-1 and its immune regulation. Autoimmunity 2007; 40(2):95-102.
71. Miyagawa-Hayashino A, Tsuruyama T, Haga H, et al.: Arteriopathy in chronic allograft rejection in liver transplantation. Liver Transpl 2004; 10(4):513-519.
72. Bartlett AS, McCall JL, Ameratunga R, Yeong ML, Gane E, Munn SR: Analysis of intragraft gene and protein expression of the costimulatory molecules, CD80, CD86 and CD154, in orthotopic liver transplant recipients. Am J Transplant 2003; 3(11):1363-1368.
73. Sun H, Subbotin V, Chen C, et al.: Prevention of chronic rejection in mouse aortic allografts by combined treatment with CT- LA4-Ig and anti-CD40 ligand monoclonal antibody. Transplantation 1997; 64(12):1838-1843.
74. Kirk AD, Harlan DM, Armstrong NN, et al.: CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates. Proc Natl Acad Sci USA 1997; 94(16):8789-8794.
75. Qian S, Demetris AJ, Murase N, Rao AS, Fung JJ, Starzl TE: Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology 1994; 19(4):916-924.
76. Sato K, Yabuki K, Haba T, Maekawa T: Role of Kupffer cells in the induction of tolerance after liver transplantation. J Surg Res 1996; 63(2):433-438.
77. Roland CR, Mangino MJ, Duffy BF, Flye MW: Lymphocyte suppression by Kupffer cells prevents portal venous tolerance induction: a study of macrophage function after intravenous gadolinium. Transplantation 1993; 55(5):1151-1158.
78. Diaz-Peromingo JA, Gonzalez-Quintela A: Influence of gadolinium-induced kupffer cell blockade on portal venous tolerance in rat skin allograft transplantation. Eur Surg Res 2005; 37(1):45-49.
79. Chen Y, Liu Z, Liang S, et al.: Role of Kupffer cells in the induction of tolerance of orthotopic liver transplantation in rats. Liver Transpl 2008; 14(6):823-836.
80. MacPhee PJ, Schmidt EE, Groom AC: Intermittence of blood flow in liver sinusoids, studied by high-resolution in vivo microscopy. Am J Physiol 1995; 269(5Pt1):G692-698.
81. You Q, Cheng L, Kedl RM, Ju C: Mechanism of T cell tolerance induction by murine hepatic Kupffer cells. Hepatology 2008; 48(3):978-990.
82. Ojaniemi M, Liljeroos M, Harju K, Sormunen R, Vuolteenaho R, Hallman M: TLR-2 is upregulated and mobilized to the hepatocyte plasma membrane in the space of Disse and to the Kupffer cells TLR-4 dependently during acute endotoxemia in mice. Immunol Lett 2006; 102(2):158-168.
83. Sun D, Chen D, Du B, Pan J: Heat shock response inhibits NF-kappaB activation and cytokine production in murine Kupffer cells. J Surg Res 2005; 129(1):114-121.
84. Jahnke C, Mehrabi A, Golling M, et al.: Evaluation of microperfusion disturbances in the transplanted liver after Kupffer cell destruction using GdCl3: an experimental porcine study. Transplant Proc 2006; 38(5):1588-1595.
85. Jung JY, Lee SM: The roles of Kupffer cells in hepatic dysfunction induced by ischemia/reperfusion in rats. Arch Pharm Res 2005; 28(12):1386-1391.
86. Muschen M, Warskulat U, Peters-Regehr T, Bode JG, Kubitz R, Haussinger D: Involvement of CD95 (Apo-1/Fas) ligand expressed by rat Kupffer cells in hepatic immunoregulation. Gastroenterology 1999; 116(3):666-677.
87. Uchikura K, Wada T, Hoshino S, et al.: Lipopolysaccharides induced increases in Fas ligand expression by Kupffer cells via mechanisms dependent on reactive oxygen species. Am J Physiol Gastrointest Liver Physiol 2004; 287(3):G620-626.
88. Zhang HG, Su X, Liu D, et al.: Induction of specific T cell tolerance by Fas ligand-expressing antigen-presenting cells. J Immunol 1999; 162(3):1423-1430.
89. Sun Z, Wada T, Uchikura K, Ceppa E, Klein AS: Role of Fas/ Fasl in Kupffer cell-dependent deletion of alloantigen activated T cells following liver transplantation. Transplant Proc 2001; 33(1-2):279-282.
90. Thakur V, Pritchard MT, McMullen MR, Wang Q, Nagy LE: Chronic ethanol feeding increases activation of NADPH oxidase by lipopolysaccharide in rat Kupffer cells: role of increased reactive oxygen in LPS-stimulated ERK1/2 activation and TNF-alpha production. J Leukoc Biol 2006; 79(6):1348-1356.
91. Maemura K, Zheng Q, Wada T, et al.: Reactive oxygen species are essential mediators in antigen presentation by Kupffer cells. Immunol Cell Biol 2005; 83(4):336-343.
92. Mocellin S, Panelli MC, Wang E, Nagorsen D, Marincola FM: The dual role of IL-10. Trends Immunol 2003; 24(1):36-43.
93. Maloy KJ, Salaun L, Cahill R, Dougan G, Saunders NJ, Powrie F: CD4+CD25+ T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms. J Exp Med 2003; 197(1):111-119.
94. Zhang X, Koldzic DN, Izikson L, et al.: IL-10 is involved in the suppression of experimental autoimmune encephalomyelitis by CD25+CD4+ regulatory T cells. Int Immunol 2004; 16(2):249-256.
95. Read S, Malmstrom V, Powrie F: Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. J Exp Med 2000; 192(2):295-302.
96. Hara M, Kingsley CI, Niimi M, et al.: IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J Immunol 2001; 166(6):3789-3796.
97. Li WM, Liu W, Gao C, et al.: Antigen-specific tolerance induced by IL-10 gene modified immature dendritic cells in experimental autoimmune myocarditis in rats. Chin Med J (Engl) 2006; 119(19):1646-1652.
98. Yang S, Li W, Liu W, et al.: IL-10 gene modified dendritic cells induced antigen-specific tolerance in experimental autoimmune myocarditis. Clin Immunol 2006; 121(1):63-73.
99. Yokoyama Y, Kitchens WC, Toth B, et al.: Role of IL-10 in regulating proinflammatory cytokine release by Kupffer cells following trauma-hemorrhage. Am J Physiol Gastrointest Liver Physiol 2004; 286(6):G942-946.